Companies: 10,795·Total market cap: $144.5T
Orexo AB (publ)

Orexo AB (publ)

ORXOFOTCHealthcare● Active
$2.90
+$0.80(+38.10%)
Market Cap$101866717
P/E Ratio
52W High$3.23
52W Low$1.08

Orexo AB (publ) (ORXOF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · ORXOF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$25.93M$590.00M$638.80M$624.30M$565.00M
Cost of Revenue$81.30M$72.10M$88.90M$102.60M$78.90M
Gross Profit($55.36M)$517.90M$549.90M$521.70M$486.10M
Gross Margin %(computed)-213.46%87.78%86.08%83.57%86.04%
Operating Expenses
R&D Expenses$232.52M$340.00M$303.10M$318.00M$272.30M
G&A Expenses$0.00M$165.30M$188.00M$202.30M$151.50M
Total Operating Expenses$290.67M$658.20M$659.40M$735.90M$711.00M
Operating Income($346.03M)($140.30M)($109.50M)($214.20M)($224.90M)
Operating Margin %(computed)-23.78%-17.14%-34.31%-39.81%
Interest Income$0.00M$7.30M$7.80M$4.00M$0.00M
Interest Expense$50.17M$60.00M$41.20M$27.80M$28.20M
Income Before Tax($401.99M)($190.60M)($140.30M)($170.40M)($222.50M)
Income Tax Expense$0.30M$12.40M($12.00M)$7.20M$1.00M
Net Income($129.47M)($203.00M)($128.30M)($177.60M)($223.50M)
Net Margin %(computed)-499.23%-34.41%-20.08%-28.45%-39.56%
Per Share & EBITDA
EPS (Basic)$-3.74$-5.89$-3.73$-5.17$-6.51
Wtd Avg Shares34.63M34.63M34.40M34.35M34.32M
EBITDA($285.18M)$13.00M($22.00M)($73.90M)($141.30M)
EBITDA Margin %(computed)2.20%-3.44%-11.84%-25.01%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SEK · M

Explore more Orexo AB (publ) data

About Orexo AB (publ) (ORXOF) Income Statement

Orexo AB (publ) (ORXOF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ORXOF reported revenue of $0.03B, gross profit of ($0.06B) (gross margin -213.46%), and net income of ($0.13B) — a net profit margin of -499.23%.

Frequently asked questions

ORXOF · 4 questions

Orexo AB (publ) (ORXOF) reported revenue of $0.03B for 2025, down 95.6% year-over-year.

ORXOF revenueORXOF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09